These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9727307)

  • 21. Risperidone and late onset tics.
    Feroz-Nainar C; Roy M
    Autism; 2006 May; 10(3):302-7. PubMed ID: 16682400
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of generalized tardive dystonia with clozapine.
    Aukst-Margetić B; Margetić B
    Psychiatr Danub; 2008 Sep; 20(3):329-31. PubMed ID: 18827758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TD from risperidone?
    Edleman RJ
    J Am Acad Child Adolesc Psychiatry; 1997 Jul; 36(7):867. PubMed ID: 9204659
    [No Abstract]   [Full Text] [Related]  

  • 24. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia in an autistic patient treated with risperidone.
    Kwon H
    Am J Psychiatry; 2004 Apr; 161(4):757-8. PubMed ID: 15056529
    [No Abstract]   [Full Text] [Related]  

  • 26. Risperidone-induced tardive dyskinesia in first-episode psychotic patients.
    Campbell M
    J Clin Psychopharmacol; 1999 Jun; 19(3):276-7. PubMed ID: 10350038
    [No Abstract]   [Full Text] [Related]  

  • 27. Chorea and tardive dyskinesia in a patient taking risperidone.
    Carroll NB; Boehm KE; Strickland RT
    J Clin Psychiatry; 1999 Jul; 60(7):485-7. PubMed ID: 10453805
    [No Abstract]   [Full Text] [Related]  

  • 28. Risperidone-induced tardive dyskinesia.
    Saran BM
    J Clin Psychiatry; 1998 Jan; 59(1):29-30. PubMed ID: 9491064
    [No Abstract]   [Full Text] [Related]  

  • 29. Tardive dyskinesia from risperidone and olanzapine in an alcoholic man.
    Snoddgrass PL; Labbate LA
    Can J Psychiatry; 1999 Nov; 44(9):921. PubMed ID: 10584163
    [No Abstract]   [Full Text] [Related]  

  • 30. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible and irreversible tardive dyskinesia: a case report.
    Chouinard G; Bradwejn J
    Am J Psychiatry; 1982 Mar; 139(3):360-2. PubMed ID: 6120657
    [No Abstract]   [Full Text] [Related]  

  • 32. [Risperidone-induced tardive dystonia: a case of torticollis].
    Fdhil H; Krebs MO; Bayle F; Vanelle JM; Olie JP
    Encephale; 1998; 24(6):581-3. PubMed ID: 9949942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone-induced tardive dyskinesia.
    Buzan RD
    Am J Psychiatry; 1996 May; 153(5):734-5. PubMed ID: 8615429
    [No Abstract]   [Full Text] [Related]  

  • 34. Risperidone, tardive dyskinesia, and the elderly.
    Chaplin RH
    Am J Psychiatry; 2001 Aug; 158(8):1336-7. PubMed ID: 11481187
    [No Abstract]   [Full Text] [Related]  

  • 35. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety of risperidone.
    Davidson M
    J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tics with risperidone withdrawal.
    Rowan AB; Malone RP
    J Am Acad Child Adolesc Psychiatry; 1997 Feb; 36(2):162-3. PubMed ID: 9031567
    [No Abstract]   [Full Text] [Related]  

  • 39. Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use.
    Caley CF
    Can J Psychiatry; 1998 Apr; 43(3):307-8. PubMed ID: 9561323
    [No Abstract]   [Full Text] [Related]  

  • 40. Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidone.
    Silver H; Aharon N; Schwartz M
    J Clin Psychopharmacol; 2000 Feb; 20(1):112-4. PubMed ID: 10653224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.